Masanao Inagaki
Osaka University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Masanao Inagaki.
Tetrahedron Letters | 1991
Yasuyuki Kita; Hirofumi Tohma; Masanao Inagaki; Kenji Hatanaka; Takayuki Yakura
Abstract A novel and useful method for the azidation of aromatic compounds by the reaction of hypervalent iodine reagent, phenyliodine(III) bis(trifluoroacetate) (PIFA) in 1,1,1,3,3,3-hexafluoro-2-propanol followed by treatment of trimethylsilyl azide (TMSA) was developed. The possible mechanism is also discussed.
Journal of Medicinal Chemistry | 2003
Susumu Mitsumori; Tatsuo Tsuri; Tsunetoshi Honma; Yoshiharu Hiramatsu; Toshihiko Okada; Hiroshi Hashizume; Shiro Kida; Masanao Inagaki; Akinori Arimura; Kiyoshi Yasui; Fujio Asanuma; Junji Kishino; Mitsuaki Ohtani
In an earlier paper, we reported that novel prostaglandin D(2) (PGD(2)) receptor antagonists having the bicyclo[2.2.1]heptane ring system as a prostaglandin skeleton were a potent new class of antiallergic agents and suppressed various allergic inflammatory responses such as those observed in conjunctivitis and asthma models. In the present study, we synthesized PGD(2) receptor antagonists having the 6,6-dimethylbicyclo[3.1.1]heptane ring system. These derivatives have the amide moiety, in contrast to those with the bicyclo[2.2.1]heptane ring system, which have the sulfonamide group. The derivatives having the 6,6-dimethylbicyclo[3.1.1]heptane ring also exhibited strong activity in PGD(2) receptor binding and cAMP formation assays. In in vivo assays such as allergic rhinitis, conjunctivitis, and asthma models, these series of derivatives showed excellent pharmacological profiles. In particular, compound 45 also effectively suppressed eosinophil infiltration in allergic rhinitis and asthma models. This compound (45, S-5751) is now being developed as a promising alternative antiallergic drug candidate.
Tetrahedron Letters | 1991
Yasuyuki Kita; Hirofumi Tohma; Masanao Inagaki; Kenji Hatanaka; Kazumi Kikuchi; Takayuki Yakura
Abstract Hypervalent iodine oxidation of O-silyated phenols bearing various types of aminoquinones at the p-position in 2,2,2-trifluoroethanol gave azacarbocyclic spirodienones in good yields and application of this reaction to the synthetic approach to discorhabdin C was also described.
Bioorganic & Medicinal Chemistry Letters | 2012
Masahide Odan; Natsuki Ishizuka; Yoshiharu Hiramatsu; Masanao Inagaki; Hiroshi Hashizume; Yasuhiko Fujii; Susumu Mitsumori; Yasuhide Morioka; Masahiko Soga; Masashi Deguchi; Kiyoshi Yasui; Akinori Arimura
The discovery of novel CB2 ligands based on the 3-carbamoyl-2-pyridone derivatives by adjusting the size of side chain at 1-, 5- and 6-position is reported. The structure-activity relationship around this template lead to the identification of S-777469 as a selective CB2 receptor agonist, which exhibited the significant inhibition of scratching induced by Compound 48/80 at 1.0 mg/kg po and 10 mg/kg po (55% and 61%, respectively).
Heterocycles | 1992
Yasuyuki Kita; Hirofumi Tohma; Masanao Inagaki; Kenji Hatanaka
A general and high-yield synthesis of benzoquinone imines and benzoquinone imine monoacetals leading to 5-oxygenated indoles was developed
Journal of The Chemical Society, Chemical Communications | 1992
Yasuyuki Kita; Ryuichi Okunaka; Maiko Kondo; Hirofumi Tohma; Masanao Inagaki; Kenji Hatanaka
A novel and efficient intramolecular aromatic alkylation of α-(aryl)alkyl β-dicarbonyl derivatives using the hypervalent iodine reagent, phenyliodine(III) bis(trifluoroacetate)(PIFA), is described.
Bioorganic & Medicinal Chemistry Letters | 2012
Masahide Odan; Natsuki Ishizuka; Yoshiharu Hiramatsu; Masanao Inagaki; Hiroshi Hashizume; Yasuhiko Fujii; Susumu Mitsumori; Yasuhide Morioka; Masahiko Soga; Masashi Deguchi; Kiyoshi Yasui; Akinori Arimura
The optimization of a series of 3-carbamoyl 2-pyridone derivatives as CB agonists is reported. These efforts resulted in the discovery of 3-(2-(1-(cyclohexylmethyl)-2-oxo-1,2,5,6,7,8,9,10-octahydrocycloocta[b]pyridine-3-carboxamido)thiazol-4-yl)propanoic acid (21), a potent dual CB1/CB2 agonist without CNS side effects induced by CB1 receptor activation. It exhibited strong inhibition of scratching as a 1.0% acetone solution in the pruritic model.
Angewandte Chemie | 1998
Kenji Kawada; Akinori Arimura; Tatsuo Tsuri; Masahiro Fuji; Tadafumi Komurasaki; Shuji Yonezawa; Akira Kugimiya; Nobuhiro Haga; Susumu Mitsumori; Masanao Inagaki; Takuji Nakatani; Yoshinori Tamura; Shozo Takechi; Teruhiko Taishi; Junji Kishino; Mitsuaki Ohtani
Regioselektive Halogenierungen und Suzuki-Reaktionen ermoglichen die richtige Verknupfung der aromatischen Ringe in zwei Totalsynthesen von Terprenin 1. Durch beide Reaktionswege kann 1 effizient und in groserer Menge erhalten werden.
Bioorganic & Medicinal Chemistry Letters | 2012
Masahide Odan; Natsuki Ishizuka; Yoshiharu Hiramatsu; Masanao Inagaki; Hiroshi Hashizume; Yasuhiko Fujii; Susumu Mitsumori; Yasuhide Morioka; Masahiko Soga; Masashi Deguchi; Kiyoshi Yasui; Akinori Arimura
Our lead compound 1 showed high affinity for both CB1 and CB2 receptors, suggesting the possibility of inducing psychoactive side effects through the CB1 receptor in the brain. To solve this issue, polar functional groups were introduced at the 3-position of the pyridone core of compound 1 to find CB1/2 dual agonists such as 17 and 20 which did not show any CNS side effects.
Bioorganic & Medicinal Chemistry | 2003
Masanao Inagaki; Hirokuni Jyoyama; Takashi Ono; Katsutoshi Yamada; Mika Kobayashi; Takahiko Baba; Akira Touchi; Kouji Iwatani; Tomoyuki Ohkawa; Saichi Matsumoto; Tatsuo Tsuri
We have synthesized and characterized some oxidative metabolites of S-2474. In this study, we discovered a novel skeleton, the 2,3-dihydrobenzofuran derivative, which inhibited PGE(2) production at a very low concentration and was effective in the anti-carrageenin footpad edema assay.